Premium
AIF suppresses chemical stress‐induced apoptosis and maintains the transformed state of tumor cells
Author(s) -
Urbano Alexander,
Lakshmanan Umayal,
Choo Poh Heok,
Kwan Jair Chau,
Ng Poh Yong,
Guo Ke,
Dhakshinamoorthy Saravanakumar,
Porter Alan
Publication year - 2005
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1038/sj.emboj.7600746
Subject(s) - apoptosis inducing factor , apoptosis , transfection , reactive oxygen species , mitochondrion , superoxide , microbiology and biotechnology , oxidative stress , biology , gene knockdown , chemistry , programmed cell death , cell culture , biochemistry , enzyme , caspase , genetics
Apoptosis‐inducing factor (AIF) exhibits reactive oxygen species (ROS)‐generating NADH oxidase activity of unknown significance, which is dispensable for apoptosis. We knocked out the aif gene in two human colon carcinoma cell lines that displayed lower mitochondrial complex I oxidoreductase activity and produced less ROS, but showed increased sensitivity to peroxide‐ or drug‐induced apoptosis. AIF knockout cells failed to form tumors in athymic mice or grow in soft agar. Only AIF with intact NADH oxidase activity restored complex I activity and anchorage‐independent growth of aif knockout cells, and induced aif ‐transfected mouse NIH3T3 cells to form foci. AIF knockdown in different carcinoma cell types resulted in lower superoxide levels, enhanced apoptosis sensitivity and loss of tumorigenicity. Antioxidants sensitized AIF‐expressing cells to apoptosis, but had no effect on tumorigenicity. In summary, AIF‐mediated resistance to chemical stress involves ROS and probably also mitochondrial complex I. AIF maintains the transformed state of colon cancer cells through its NADH oxidase activity, by mechanisms that involve complex I function. On both counts, AIF represents a novel type of cancer drug target.